Klaus Pusecker

Title: Klaus Pusecker: Innovator in Transdermal Therapeutics

Introduction

Klaus Pusecker is a notable inventor based in Korschenbroich, Germany. He has made significant contributions to the field of transdermal therapeutic systems, particularly through his innovative work involving the NMDA receptor antagonist memantine. His research and inventions have the potential to impact the treatment of various central nervous system diseases.

Latest Patents

Klaus Pusecker holds a patent for the transdermal administration of memantine. This invention relates to transdermal therapeutic systems (TTS) that utilize memantine or its physiologically compatible salts as the active ingredient. These systems are designed to provide effective treatment options for diseases affecting the central nervous system.

Career Highlights

Throughout his career, Klaus Pusecker has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with LTS Lohmann Therapie-Systeme AG and Grünenthal GmbH. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Klaus Pusecker has collaborated with several professionals in his field, including René Eifler and Michael Horstmann. These partnerships have facilitated the advancement of his research and the successful development of his patented technologies.

Conclusion

Klaus Pusecker's work in transdermal therapeutic systems exemplifies the innovative spirit of modern medicine. His contributions are paving the way for new treatment options for patients with central nervous system disorders.